Internal Reference Number: FOI_5704
Date Request Received: 22/06/2020 10:04:09
Date Request Replied To: 03/08/2020 08:35:44
This response was sent via: By Email
Request Summary: Ophthalmology new patients
Request Category: Companies
|Question Number 1:|
Within your Trust, how many patients, in the most recent 12-month period for which data are available, have received anti-VEGF treatment for the first time (i.e., excluding patients who previously had any anti-VEGF therapy)?
|Answer To Question 1:|
247 patients underwent their first anti-VEGF treatment
|Question Number 2:|
Of these first-time patients, please provide a breakdown by the treatments listed below:
All other anti-VEGF treatments
|Answer To Question 2:|
All other antiVEGF treatments 6
|Question Number 3:|
Of these first-time patients, how many were treated for Wet Age-Related Macular Degeneration (wAMD) by each treatment?
All Other anti-VEGF treatments
|Answer To Question 3:|
Brolucizumab 0 - still waiting FDA approval
Dexamethasone 0 - not an antiVEGF and therefore not used for the treatment of wet AMD
All other antiVEGF treatments 2
|To return to the list of all the FOI requests please click here|
Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.